The effect of duloxetine in quality of life and symptoms of patients with irritable bowel syndrome (IBS)

Phase 1

Completed

• Conditions: Irritable Bowel Syndrome.; Irritable Bowel Syndrome; k58.0

• Registration Number: IRCT20200928048862N1
• Lead Sponsor: Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2020-11-09

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Patients with irritable bowel syndrome (IBS)
Mild to moderate score (score less than 11) in the Anxiety and Depression Questionnaire.

Exclusion Criteria

Psychotic patients, bipolar disorder, obsessive-compulsive disorder, substance use in the last 6 months, dementia, suicidal idea
Taking psychotropic drugs in the last 2 weeks
Pregnancy and lactation
age of under 18 years old and over 65 years old
digestive bleeding
Persistent vomiting
Persistent abdominal pain
Unexplained weight loss
Crohn's, celiac disease, colon cancer, seizures, hypertension, angle-closure glaucoma,

Study & Design

• Study Type: interventional
• Study Design: Not specified